Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T20:07:01.767Z.
Consensus retrieved: 2026-10-06T12:28:51.383Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T20:07:01.767Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80f889fb03c5e90f23e6dbb960addb407f240d79d9565bd54dedfb6815f2f0ce
Forward PE Ratio (N/A) = Dated Quote Price ($50.69) / Consensus Forward EPS ($-0.41)
FORWARD PE RATIO
N/A
Heartflow, Inc. Common Stock
Market Cap
$4.37B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.37B | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.31B | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.31B | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | 8.50 |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 125.78 |
| LivaNova PLC (LIVN)vs › | $4.12B | 17.20 |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.11B | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 16.49 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 75.50 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $50.69, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.41 | $-0.45 – $-0.38 | 6 | n/m |
| 2027-12-31 | $-0.26 | $-0.47 – $-0.15 | 6 | n/m |
| 2028-12-31 | $0.07 | $-0.14 – $0.43 | 3 | 728.7x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
